In vitro digestion and fecal fermentation profiles of Cremastra appendiculata polysaccharide and evaluation of its antioxidant and hypoglycemic capacities

Clicks: 30
ID: 328723
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #88 of 219 articles by views in Journal of applied microbiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 219 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
AIMS: Cremastra appendiculata is a traditional Chinese herbal medicine for liver cancer treatment. C. appendiculata polysaccharides (CAP) as a biomacromolecular showed significant lipid-lowering activities. However, the gastrointestinal metabolic fate and the bioactivities of the fermented products remain poorly understood. METHODS AND RESULTS: Simulated salivary, gastric, intestinal digestion models, together with an in vitro human fecal fermentation system, were employed to evaluate the physicochemical profiles of CAP. Variations in molecular weight, reducing sugars, free monosaccharides, short-chain fatty acids (SCFAs), and pH were determined. 16S rRNA gene sequencing was performed to characterize alterations in fecal fermentation microbial communities, and the in vitro α-amylase and α-glucosidase inhibitory activities and antioxidant activities were assessed. As a result, during the simulated fermentation process, CAP remained structurally stable throughout simulated gastrointestinal digestion. During fecal fermentation, CAP was degraded by the fecal microbiota as the molecular weight decreased and the reducing sugars increased. Moreover, CAP significantly enhanced SCFAs production, particularly acetic acid and propionic acid, with a reduction in fermentation pH. CAP selectively enriched beneficial bacteria, including Bifidobacterium, Bacteroides, Lactobacillus and Odoribacter, while suppressing potentially harmful microorganisms, such as Proteobacteria, Bilophila, and Eggerthella. Furthermore, fecal fermentation of CAP enhanced inhibitory effects against α-amylase and α-glucosidase and antioxidant activities. CONCLUSIONS: These findings provide mechanistic insights into the health-promoting properties of CAP and support its future development as a functional food ingredient and gut microbiota regulator.
Reference Key
openalex_W7213352730 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal Journal of applied microbiology
Year 2026
DOI
10.1093/jambio/lxag238
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.